Arrivent BioPharma, Inc. (AVBP)
Arrivent BioPharma Market Cap : 1.103B for May 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ocugen, Inc. | 453.62M |
| ACADIA Pharmaceuticals, Inc. | 3.613B |
| Agenus, Inc. | 129.51M |
| Alnylam Pharmaceuticals, Inc. | 39.71B |
| Amgen, Inc. | 183.12B |
Market Cap Related Metrics
| Price to Book Value | 3.406 |
| Price | 26.73 |
| Earnings Yield | -13.21% |